NEXTRNA THERAPEUTICS
NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
NEXTRNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.nextrnatx.com
Total Employee:
11+
Status:
Active
Total Funding:
56.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Seres Therapeutics
Seres Therapeutics is a microbiome therapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Evans Capital
Evans Capital investment in Series A - NextRNA Therapeutics
Lightchain Capital
Lightchain Capital investment in Series A - NextRNA Therapeutics
Circle Squared Alternative Investments
Circle Squared Alternative Investments investment in Series A - NextRNA Therapeutics
Cobro Ventures
Cobro Ventures investment in Series A - NextRNA Therapeutics
Jefferies
Jefferies investment in Series A - NextRNA Therapeutics
Rivas Capital
Rivas Capital investment in Series A - NextRNA Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series A - NextRNA Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-08-11 | NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team |
Official Site Inspections
http://www.nextrnatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.31 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago